.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Post-tuberculosis lung disease (PTLD) has emerged as a critical contributor to long-term morbidity for millions of tuberculosis survivors globally. While achieving microbiological cure remains the priority, many patients continue to suffer from chronic respiratory impairment. Consequently, researchers are increasingly investigating various post-tuberculosis lung disease interventions to improve quality of life and lung function after treatment completion.
A comprehensive scoping review recently examined several therapeutic categories to determine their efficacy in managing PTLD. For instance, host-directed therapies (HDT) such as metformin and doxycycline showed potential in accelerating cavity resolution in small-scale trials. Similarly, corticosteroids demonstrated inconsistent signals of radiological improvement. However, the data remains sparse, and many studies were not originally designed to assess long-term lung health.
Inhaled pharmacotherapy also offers a pathway for symptom management. Specifically, two studies indicated that bronchodilators provide short-term gains in spirometric measures. Moreover, a retrospective cohort study suggested a potential survival benefit for patients using these therapies. In cases where chronic pulmonary aspergillosis complicates recovery, antifungal treatments significantly improved radiological outcomes and inflammatory biomarkers.
Despite these findings, the current evidence base for post-tuberculosis lung disease interventions is largely incidental and heterogeneous. Most historical research focused on sputum conversion rather than validated disability tools or advanced lung function measures. Therefore, clinicians must advocate for high-quality, person-centered trials to establish standardized care protocols for TB survivors.
The primary goals include reducing chronic respiratory symptoms, improving lung function (spirometry), and enhancing the overall quality of life for TB survivors who experience permanent lung damage.
Current research highlights inhaled bronchodilators for symptom relief and host-directed therapies like metformin for tissue repair. However, these require further validation in large-scale clinical trials before becoming standard practice.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Byrne AL et al. Interventions to reduce the impact of post-tuberculosis lung disease: a scoping review of the literature. BMC Pulm Med. 2026 Jun 04. doi: 10.1186/s12890-026-04355-3. PMID: 42243811.
Ravimohan S, et al. Post-tuberculosis lung disease: clinical review of an under-recognised condition. Lancet Respir Med. 2018;6(6):441-451.
Migliori GB, et al. Post-tuberculosis lung disease: a review of the current evidence. Eur Respir J. 2021;58(2):2003633.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A scoping review evaluates interventions like host-directed therapy and bronchodilators to mitigate post-tuberculosis lung disease (PTLD) in survivors....
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
